Beijing Scitop Bio-tech Co., Ltd.

Shenzhen Stock Exchange 300858.SZ

Beijing Scitop Bio-tech Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.01

Beijing Scitop Bio-tech Co., Ltd. Debt to Equity Ratio is 0.01 for the year ending December 31, 2023, a 25.87% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Beijing Scitop Bio-tech Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.00, a -49.00% change year over year.
  • Beijing Scitop Bio-tech Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.01, a -0.49% change year over year.
  • Beijing Scitop Bio-tech Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.01, a 0.00% change year over year.
  • Beijing Scitop Bio-tech Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.00, a -100.00% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
SV Wall Street
Shenzhen Stock Exchange: 300858.SZ

Beijing Scitop Bio-tech Co., Ltd.

CEO Mr. Xiaojun Liu
IPO Date July 27, 2020
Location China
Headquarters No.1-2, Yard 31
Employees 330
Sector Health Care
Industries
Biotechnology Pet Food Pharmaceuticals
Description

Beijing Scitop Bio-tech Co., Ltd. develops, produces, and sells probiotic lactic acid bacteria and related products in China. It also provides compound food additives, edible probiotic products, and animal and plant microecological preparations. Its products have applications in the food industry, health care, animal husbandry, and agricultural planting. Beijing Scitop Bio-tech Co., Ltd. was founded in 2003 and is headquartered in Beijing, China.

StockViz Staff

January 30, 2025

Any question? Send us an email